Literature DB >> 836666

Clinical and histopathologic observations in severe Vogt-Koyanagi-Harada syndrome.

H D Perry, R L Font.   

Abstract

Vogt-Koyanagi (V-K) syndrome is a severe anterior uveitis associated with alopecia, vitiligo, poliosis, and dysacousia. Harada's disease (HD) is primarily a posterior uveitis accompanied by signs of meningeal irritation and abnormalities of the cerebrospinal fluid. The overlapping of clinical manifestations between the two justified considering them as part of a spectrum of one disease (V-K-H). In a clinicopathologic study of nine cases four patients (three with V-K syndrome and one with V-K-H syndrome) histopathologically displayed a granulomatous uveitis. Five patients (two with V-K syndrome and three with HD) showed a nongranulomatous uveitis. We emphasized this latter finding, since in the past the diagnosis of this syndrome has been discarded both clinically and histopathologically because of the absence of a granulomatous uveitis. We established the clinical and histopathologic differences between V-K-H and sympathetic ophthalmia. The designation "uveomeningoencephalitic syndrome" stresses the key features of V-K-H, namely the uveal involvement and signs of meningeal irritation (that is, headaches, personality changes, and cerebrospinal fluid alterations).

Entities:  

Mesh:

Year:  1977        PMID: 836666     DOI: 10.1016/0002-9394(77)90623-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  22 in total

1.  Multifocal posterior uveitis: clinical and pathological findings.

Authors:  D G Charteris; W R Lee
Journal:  Br J Ophthalmol       Date:  1990-11       Impact factor: 4.638

2.  Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.

Authors:  Kei Nakai; Fumi Gomi; Yasushi Ikuno; Yoshiaki Yasuno; Takeyoshi Nouchi; Nobuyuki Ohguro; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-13       Impact factor: 3.117

3.  Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease.

Authors:  S Hayasaka; H Okabe; J Takahashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

4.  Visual function in Vogt-Koyanagi-Harada patients.

Authors:  Soon-Phaik Chee; Chi D Luu; Ching-Li Cheng; Wee-Kiak Lim; Aliza Jap
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-11       Impact factor: 3.117

Review 5.  Pathology of Vogt-Koyanagi-Harada disease.

Authors:  Narsing A Rao
Journal:  Int Ophthalmol       Date:  2007-04-14       Impact factor: 2.031

Review 6.  Autoimmune vertigo: an update on vestibular disorders associated with autoimmune mechanisms.

Authors:  Francesca Yoshie Russo; Massimo Ralli; Daniele De Seta; Patrizia Mancini; Alessandro Lambiase; Marco Artico; Marco de Vincentiis; Antonio Greco
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

7.  Ocular abnormalities associated with cutaneous melanoma and vitiligolike leukoderma.

Authors:  M A Chang; G Fournier; H K Koh; A J Sober; H Nakagawa; T B Fitzpatrick; D M Albert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

8.  Vitiligo and disorders of the retinal pigment epithelium.

Authors:  D M Albert; M D Wagoner; R C Pruett; J J Nordlund; A B Lerner
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

9.  Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease.

Authors:  S Otani; T Sakurai; K Yamamoto; T Fujita; Y Matsuzaki; Y Goto; Y Ando; S Suzuki; M Usui; M Takeuchi; Y Kawakami
Journal:  Br J Ophthalmol       Date:  2006-02-15       Impact factor: 4.638

10.  Subretinal neovascularization in the Vogt-Koyanagi-Harada syndrome.

Authors:  R R Ober; R E Smith; S J Ryan
Journal:  Int Ophthalmol       Date:  1983-06       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.